Engineered Fusokine GIFT4 Licenses the Ability of B Cells to Trigger a Tumoricidal T-Cell Response

Cancer Research - United States
doi 10.1158/0008-5472.can-14-0708
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search